The Prognostic and Chemotherapeutic Value of miR-296 in Esophageal Squamous Cell Carcinoma

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of Surgery

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e3181dd4ea9PMID 20485139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Many roads to maturity: microRNA biogenesis pathways and their regulation

  2009cited by this paper
• Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

  2009cited by this paper
• Protein alterations in ESCC and clinical implications: a review.

  2009cited by this paper
• MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

  2009cited by this paper
• Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription.

  2009cited by this paper
• Differential Expression Profiles of microRNAs in NIH3T3 Cells in Response to UVB Irradiation

  2009cited by this paper
• PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.

  2009cited by this paper
• Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504.

  2009cited by this paper
• AngiomiRs--key regulators of angiogenesis.

  2009cited by this paper
• MicroRNA regulation of cardiovascular development.

  2009cited by this paper
• miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.

  2008cited by this paper
• MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation

  2008cited by this paper
• Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation.

  2008cited by this paper
• Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.

  2008cited by this paper
• Concise Review: MicroRNA Expression in Multipotent Mesenchymal Stromal Cells

  2008cited by this paper
• MicroRNA expression in cytogenetically normal acute myeloid leukemia.

  2008cited by this paper
• Reversal of multidrug resistance of vincristine‐resistant gastric adenocarcinoma cells through up‐regulation of DARPP‐32

  2007cited by this paper
• MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

  2007cited by this paper
• ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.

  2006cited by this paper
• Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2

  2005cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• Chemotherapeutic agents that induce mitochondrial apoptosis.

  2004cited by this paper
• L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

  2003cited by this paper
• Molecular biology of esophageal squamous cell carcinoma.

  2000cited by this paper
• Prognostic Value of p27Kip1 and CyclinD1 Expression in Esophageal Cancer

  1999cited by this paper

• MicroRNAs in Esophageal Cancer: Implications for Diagnosis, Progression, Prognosis and Chemoresistance

  2026cites this paper
• Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view

  2024cites this paper
• Sphingosine kinase 2 controls the aggressive phenotype of oral squamous cell carcinoma by regulating miR-205 and miR-296 through p53.

  2024cites this paper
• Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.

  2023cites this paper
• The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer.

  2023cites this paper
• Prediction of potential miRNA-disease associations based on stacked autoencoder

  2022cites this paper
• SOX17-mediated MALAT1-miR-199a-HIF1α axis confers sensitivity in esophageal squamous cell carcinoma cells to radiotherapy

  2022cites this paper
• ABC transporters in breast cancer: their roles in multidrug resistance and beyond

  2022cites this paper
• Regulation of drug transporters by microRNA and implications in disease treatment

  2021cites this paper
• Regulation of drug transporters by microRNA and implications in disease treatment

  2021cites this paper
• The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors

  2021cites this paper
• MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome

  2021cites this paper
• Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas

  2021cites this paper
• Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer

  2021cites this paper
• In Hepatocellular Carcinoma, miRNA-296-3p Targets MSL2 and Suppresses Cell Proliferation and Invasion

  2021cites this paper
• P-Glycoprotein Efflux Transporters and Its Resistance Its Inhibitors and Therapeutic Aspects

  2020cites this paper
• CircPSMC3 alleviates the symptoms of PCOS by sponging miR‐296‐3p and regulating PTEN expression

  2020cites this paper
• Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy

  2020cites this paper
• Esophageal Squamous Cell Carcinoma: Methods and Protocols

  2020cites this paper
• Roles of MicroRNAs in Esophageal Squamous Cell Carcinoma Pathogenesis.

  2020cites this paper
• Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma

  2020cites this paper
• Screening of differentially expressed miRNAs in tensile strain-treated HepG2 cells by miRNA microarray analysis

  2020cites this paper
• Involvement of MicroRNA-296 in the Inhibitory Effect of Epigallocatechin Gallate against the Migratory Properties of Anoikis-Resistant Nasopharyngeal Carcinoma Cells

  2020cites this paper
• ncRNAs associated with drug resistance and the therapy of digestive system neoplasms

  2019cites this paper
• ABC Transporter-Mediated Multidrug-Resistant Cancer.

  2019cites this paper
• Long noncoding RNA AK089579 inhibits epithelial‐to‐mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA‐296‐3p via DOK2 in peritoneal fibrosis

  2019cites this paper
• Long-term effects of radiation prior to surgery and chemotherapy on survival of esophageal cancer undergoing surgery

  2019cites this paper
• RETRACTED ARTICLE: Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6

  2019cites this paper
• Advances in prognostic biomarkers for esophageal cancer

  2018cites this paper
• MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial–mesenchymal transition in anaplastic thyroid cancer cells

  2018cites this paper
• MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung

  2018cites this paper
• Detection and Quantification of MicroRNAs in Esophageal Adenocarcinoma.

  2018cites this paper
• How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?

  2018cites this paper
• ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer

  2018influential citation
• Plasma Glycoprotein Efflux Induced Resistance: Implications, Mechanism, Inhibitors, and Novel Strategies to Overcome

  2018cites this paper
• The promising role of miR-296 in human cancer.

  2018cites this paper
• MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?

  2018influential citation
• MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer

  2018cites this paper
• Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers

  2018cites this paper
• miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.

  2018cites this paper
• A Brief review of Circulating MicroRNAs and Essential Hypertension

  2018cites this paper
• Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients.

  2017cites this paper
• MicroRNA‑296 targets AKT2 in pancreatic cancer and functions as a potential tumor suppressor.

  2017cites this paper
• Clinical value of integrated‐signature miRNAs in esophageal cancer

  2017cites this paper
• Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer

  2017cites this paper
• Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma.

  2017cites this paper
• MicroRNA‑296‑5p downregulated AKT2 to inhibit hepatocellular carcinoma cell proliferation, migration and invasion.

  2017cites this paper
• MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets

  2017cites this paper
• The therapeutic potential of targeting ABC transporters to combat multi-drug resistance

  2017cites this paper
• MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy

  2016cites this paper
• Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies.

  2016cites this paper
• HNSCC Biomarkers Derived from Key Processes of Cancerogenesis

  2016cites this paper
• The Role of Astrocyte-Derived Factors in the Regulation of Multidrug Resistance at the Developing Blood-Brain Barrier

  2016cites this paper
• Cancer stem cells in human gastrointestinal cancer

  2016cites this paper
• A novel serum microRNA signature to screen esophageal squamous cell carcinoma

  2016cites this paper
• MiR-296 promotes colorectal cancer cells growth through regulating NF-κB

  2016cites this paper
• Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN

  2016cites this paper
• Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells

  2016cites this paper
• Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis.

  2016cites this paper
• Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer

  2016cites this paper
• The effect of chemically modified electrospun silica nanofiber on the mRNA and miRNA expression profile of neural stem cell differentiation.

  2016cites this paper
• Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.

  2016cites this paper
• Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.

  2016cites this paper
• miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression

  2016cites this paper
• miR‐483‐3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24

  2016cites this paper
• microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment.

  2015cites this paper
• Lung Cancer Stem Cells and Their Therapeutic Targeting

  2015cites this paper
• Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma

  2015cites this paper
• Angiomirs expression profiling in diffuse large B-Cell lymphoma

  2015cites this paper
• Differential MicroRNA Expression in Human Macrophages with Mycobacterium tuberculosis Infection of Beijing/W and Non-Beijing/W Strain Types

  2015cites this paper
• Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma

  2015cites this paper
• Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review

  2015cites this paper
• Prognostic markers in esophageal cancer: from basic research to clinical use

  2015cites this paper
• Age‐Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver

  2015cites this paper
• miRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy.

  2015cites this paper
• MicroRNAs in Cancer Drug Resistance and Drug Sensitivity

  2014cites this paper
• Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer.

  2014cites this paper
• The MicroRNAs as Prognostic Biomarkers for Survival in Esophageal Cancer: A Meta-Analysis

  2014cites this paper
• MicroRNAs and their relevance to ABC transporters.

  2014cites this paper
• MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets

  2014cites this paper
• Drug resistance-related miRNAs in hepatocellular cancer

  2014cites this paper
• MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance

  2014cites this paper
• Prognosis-related microRNAs in esophageal cancer

  2014cites this paper
• miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.

  2014cites this paper
• MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.

  2014cites this paper
• MicroRNAs and Their Clinical Impact on Resistance to Anticancer Treatment

  2014cites this paper
• MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1

  2014cites this paper
• Role mikroRNA v molekulární patologii

  2014cites this paper
• Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

  2014cites this paper
• Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis

  2014cites this paper
• Role mikroRNA v molekulární patologii karcinomu jícnu a jejich potenciální využití v klinické onkologii

  2014cites this paper
• Comparison of long non-coding RNAs, microRNAs and messenger RNAs involved in initiation and progression of esophageal squamous cell carcinoma

  2014cites this paper
• Drug resistance-related miRNAs in hepatocellular

  2014cites this paper
• Effect of early oral feeding on short-term outcome of patients receiving laparoscopic distal gastrectomy: a retrospective cohort study.

  2014cites this paper
• The potential role of microRNA-based therapy for lung cancer stem cells

  2014cites this paper
• A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma

  2014cites this paper
• miR-296 and Modulation of tumor growth in systemic malignancies.

  2013cites this paper
• Novel diagnostic and prognostic biomarkers in esophageal cancer.

  2013cites this paper
• The role of microRNAs in cancers of the upper gastrointestinal tract

  2013cites this paper
• Function of miRNA in controlling drug resistance of human cancers.

  2013cites this paper